Thermo Fisher introduces cell therapy workflow media

By The Science Advisory Board staff writers

January 27, 2021 -- Thermo Fisher Scientific has launched a new medium of the first human T lymphocytes (T cells) specifically designed for allogeneic cell therapy workflows.

The Gibco CTS OpTmizer Pro Serum Free Media (SFM) targets the metabolism of healthy donor cells, making it well-suited for use in the production of allogeneic, off-the-shelf cell therapies. The serum free media is compatible with automated and longer workflows and is suited for a closed system. SFM enhances donor T-cell proliferation, maintains central memory T cells further into expansion, and delays effector differentiation of healthy donor T cells, according to the company.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.